Experience

Aifred Health closes $4 million seed financing to improve mental health

Reading Time 1 minute read
Share

Overview

Client

Aifred Health

On December 8, 2020, Aifred Health, a Montreal-based digital healthcare company, announced the closing of a $4 million seed financing. This transaction will help to fund the North American regulatory approval clinical trial designed to test the safety and effectiveness of Aifred's artificial intelligence technology to recommend personalized therapeutic treatment choice for patients suffering from clinical depression.

The $4 million raise was co-led by MEDTEQ+ and BDC Capital, with additional support from the Desjardins Group, Highline Beta and other private and institutional investors including follow-on investments from most of the investors in the Company's 2019 pre-seed financing.

A Fasken team comprised of Constantinos Ragas and Jonathan Raizenne advised Aifred Health in connection with this significant financing.

Jurisdiction

  • Québec

Team

  • Constantinos Ragas, Partner | National Co-Leader, Emerging Technology & Venture Capital, Montréal, QC, +1 514 397 5244, [email protected]
Constantinos Ragas Montréal Lawyer/Avocat Constantinos Ragas Partner | National Co-Leader, Emerging Technology & Venture Capital Montréal, QC +1 514 397 5244

    You might be interested in...

    • Votorantim Cimentos and McInnis Cement to Combine Cement Operations in North America, [Deal - Caisse de dépôt et placement du Québec], St. Marys Cement Inc. (Canada), a wholly owned subsidiary of Votorantim Cimentos, and McInnis Cement Inc. agreed to combine their assets to create a combined an entity to manufacture, distribute and sell cement in Canada and the United States. The joint venture will be owned by Votorantim Cimento...
    • Nomad Royalty Company Ltd. Closes a $25 million Secondary Offering of Common Shares by Yamana Gold Inc., [Deal - Nomad Royalty Company Ltd.], On December 11, 2020, Nomad closed the secondary offering by Yamana Gold Inc. (“Yamana”) of 22,750,000 common shares of Nomad at a price of CDN $1.10 per share for total gross proceeds of CDN $25,025,000 to Yamana (the “Offering”). Nomad did not receive any proceeds from the Offering. Cormark Sec...
    • BetterLife Pharma Inc. completes $2.9 million brokered private placement offering, [Deal - Mackie Research Capital Corporation], Represented Mackie Research Capital Corporation in $2.9 million financing
    two people discussing a portfolio Deal Advised Caisse de dépôt et placement du Québec Votorantim Cimentos and McInnis Cement to Combine Cement Operations in North America St. Marys Cement Inc. (Canada), a wholly owned subsidiary of Votorantim Cimentos, and McInnis Cement Inc. agreed to combine their assets to create a combined an entity to manufacture, distribute and sell cement in Canada and the United States. The joint venture will be owned by Votorantim Cimento... Read more
    handshake deal Deal Advised Nomad Royalty Company Ltd. Nomad Royalty Company Ltd. Closes a $25 million Secondary Offering of Common Shares by Yamana Gold Inc. On December 11, 2020, Nomad closed the secondary offering by Yamana Gold Inc. (“Yamana”) of 22,750,000 common shares of Nomad at a price of CDN $1.10 per share for total gross proceeds of CDN $25,025,000 to Yamana (the “Offering”). Nomad did not receive any proceeds from the Offering. Cormark Sec... Read more
    Advised Mackie Research Capital Corporation Deal Advised Mackie Research Capital Corporation BetterLife Pharma Inc. completes $2.9 million brokered private placement offering Represented Mackie Research Capital Corporation in $2.9 million financing Read more